| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |